URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare®) for the Treatment of Urinary Dysfunction in Parkinson's Disease

Kelly L. Sullivan

URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare®) for the Treatment of Urinary Dysfunction in Parkinson's Disease

Kelly L. Sullivan

Biostatistics, Epidemiology & Environmental Health Sciences

Research output: Other contribution › Other

Original language	American English
State	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Disciplines

Epidemiology
Public Health

Cite this

@misc{d7f1dc5e81c84c3aa24d5ffe11a7ccff,

title = "URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare{\textregistered}) for the Treatment of Urinary Dysfunction in Parkinson's Disease",

author = "Sullivan, \{Kelly L.\}",

note = "Kelly L. Sullivan(Project Manager \& Epidemiologist), {"}URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare{\textregistered}) for the Treatment of Urinary Dysfunction in Parkinson's Disease,{"} Investigator Initiated. (2006-present).",

year = "2006",

language = "American English",

type = "Other",

}

TY - GEN

T1 - URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare®) for the Treatment of Urinary Dysfunction in Parkinson's Disease

AU - Sullivan, Kelly L.

N1 - Kelly L. Sullivan(Project Manager & Epidemiologist), "URGE-PD: A Multi-Site, Double-Blind, Randomized, Placebo Controlled Trial of Solifenacin Succinate (VESIcare®) for the Treatment of Urinary Dysfunction in Parkinson's Disease," Investigator Initiated. (2006-present).

PY - 2006

Y1 - 2006

M3 - Other

ER -